var data={"title":"Evaluation and prognosis of Eisenmenger syndrome","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Evaluation and prognosis of Eisenmenger syndrome</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/evaluation-and-prognosis-of-eisenmenger-syndrome/contributors\" class=\"contributor contributor_credentials\">Heidi M Connolly, MD, FASE</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/evaluation-and-prognosis-of-eisenmenger-syndrome/contributors\" class=\"contributor contributor_credentials\">John K Triedman, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/evaluation-and-prognosis-of-eisenmenger-syndrome/contributors\" class=\"contributor contributor_credentials\">Susan B Yeon, MD, JD, FACC</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/evaluation-and-prognosis-of-eisenmenger-syndrome/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Jan 05, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The triad of systemic-to-pulmonary congenital cardiovascular communication, pulmonary arterial disease, and cyanosis is called Eisenmenger syndrome. The diagnosis of Eisenmenger syndrome implies that pulmonary arterial disease has developed as a consequence of increased pulmonary blood flow, and requires exclusion of other causes of pulmonary hypertension.</p><p>In 1897, Eisenmenger described a syndrome in which pulmonary vascular disease developed in patients with a nonrestrictive ventricular septal defect [<a href=\"https://www.uptodate.com/contents/evaluation-and-prognosis-of-eisenmenger-syndrome/abstract/1\" class=\"abstract_t\">1</a>]. It was subsequently shown that pulmonary vascular disease could also occur with other congenital cardiac defects in which a systemic-to-pulmonary communication is present such as atrial shunts, other ventricular shunts, and aortic shunts (<a href=\"image.htm?imageKey=CARD%2F55944\" class=\"graphic graphic_table graphicRef55944 \">table 1</a>).</p><p>Such conditions are often associated with an initial left-to-right shunt. Increased pulmonary blood flow as a result of the shunt leads to the development of pulmonary vascular disease with increased pulmonary vascular resistance (PVR). The shunt may then reverse and become right-to-left (<a href=\"image.htm?imageKey=CARD%2F52487%7ECARD%2F70502\" class=\"graphic graphic_figure graphicRef52487 graphicRef70502 \">figure 1A-B</a> and <a href=\"image.htm?imageKey=CARD%2F58708\" class=\"graphic graphic_algorithm graphicRef58708 \">algorithm 1</a>) [<a href=\"https://www.uptodate.com/contents/evaluation-and-prognosis-of-eisenmenger-syndrome/abstract/2,3\" class=\"abstract_t\">2,3</a>]. At this stage, the patient typically becomes cyanotic.</p><p>With the advent of surgical correction of congenital heart disease (CHD), the prevalence of Eisenmenger syndrome has declined but is not negligible. This topic will review the general features, evaluation, and prognosis of CHD-related pulmonary arterial hypertension and Eisenmenger syndrome. The pathology and pathophysiology of pulmonary hypertension in Eisenmenger syndrome are discussed in detail separately. (See <a href=\"topic.htm?path=the-epidemiology-and-pathogenesis-of-pulmonary-arterial-hypertension-group-1\" class=\"medical medical_review\">&quot;The epidemiology and pathogenesis of pulmonary arterial hypertension (Group 1)&quot;</a>.)</p><p>The medical management of patients with Eisenmenger syndrome is discussed separately. (See <a href=\"topic.htm?path=management-of-eisenmenger-syndrome\" class=\"medical medical_review\">&quot;Management of Eisenmenger syndrome&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">GENERAL FEATURES</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The diagnosis of Eisenmenger syndrome requires the presence of congenital heart disease. In some cases, the diagnosis is not established until adulthood, after the development of symptoms or even overt signs of pulmonary hypertension such as syncope, atrial and ventricular arrhythmias, cyanosis, and as late findings, both right and left heart failure.</p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h2\">Anatomy and physiology</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The development of Eisenmenger syndrome may accompany a variety of forms of congenital heart disease (CHD). In one study of 201 patients, the most common defects were ventricular septal defects (33 percent), atrial septal defects (30 percent), and patent ductus arteriosus (14 percent) [<a href=\"https://www.uptodate.com/contents/evaluation-and-prognosis-of-eisenmenger-syndrome/abstract/4\" class=\"abstract_t\">4</a>]. Other disorders, including complex anatomic abnormalities, can also be associated with the Eisenmenger syndrome. In all cases, a communication between the systemic and pulmonary circulations is present. In some conditions, the normal anatomic relations between the atria, ventricles, and great vessels may be altered. For simplicity, in the discussions that follow, the term &quot;right ventricle&quot; will be used to describe the ventricle from which the main pulmonary artery arises; the term &quot;left ventricle&quot; will be used to describe the ventricle from which the aorta arises.</p><p>Systemic-to-pulmonary communications usually do not have major effects on fetal blood flow pathways. Right-to-left shunting at the atrial level (across the foramen ovale) is normal in utero, and the high pulmonary vascular resistance (PVR) of the fetus limits left-to-right shunting. In the postnatal period, there is normally a rapid decline in pulmonary vascular resistance and an increase in right ventricular compliance, resulting in a left-to-right shunt and an increase in pulmonary blood flow.</p><p>In most patients with systemic-to-pulmonary communications, shunting occurs to some degree in both directions. This is not surprising since, during the cardiac cycle, there are changes in intrathoracic pressure associated with respiration, and changes in venous return associated with exercise, changes in position, and other factors. As a result, the pressure gradient across such communications varies with time. The convention of referring to a shunt as &quot;left-to-right&quot; or &quot;right-to-left&quot; is therefore typically an expression of the <strong>net</strong> result of bidirectional shunting.</p><p>The extent of extra flow is assessed as the ratio of measured pulmonary blood flow (Qp) to systemic blood flow (Qs). In the normal case, where no connection exists, the ratio Qp:Qs is 1:1. Net left-to-right shunting results in a Qp:Qs &gt;1, while net right-to-left shunting results in a Qp:Qs &lt;1. For example, a Qp:Qs of 2:1 indicates that the pulmonary blood flow is twice that of systemic blood flow. (See <a href=\"topic.htm?path=pathophysiology-of-left-to-right-shunts\" class=\"medical medical_review\">&quot;Pathophysiology of left-to-right shunts&quot;</a>.)</p><p>The increase in pulmonary blood flow with net left-to-right shunting eventually leads to pulmonary vascular disease (<a href=\"image.htm?imageKey=CARD%2F64141\" class=\"graphic graphic_picture graphicRef64141 \">picture 1</a>) and increased pulmonary vascular resistance. The increase in pulmonary vascular resistance results in a rise in pulmonary artery pressure which is called &quot;pulmonary arteriolar hypertension&quot; (PAH) to emphasize the etiologic influence of disease in the pulmonary arterioles. Pulmonary arteriolar hypertension causes reversal of the shunt and net right-to-left shunting (Qp:Qs &lt;1) (<a href=\"image.htm?imageKey=CARD%2F58708\" class=\"graphic graphic_algorithm graphicRef58708 \">algorithm 1</a>). With shunt reversal, venous blood returning to the right side of the heart passes through the communication, reducing the oxygen saturation of the arterial blood in the left heart and causing cyanosis. (See <a href=\"topic.htm?path=the-epidemiology-and-pathogenesis-of-pulmonary-arterial-hypertension-group-1\" class=\"medical medical_review\">&quot;The epidemiology and pathogenesis of pulmonary arterial hypertension (Group 1)&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h3\">Shunt size and defect type</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The risk of developing the Eisenmenger syndrome appears to be determined by the size of the initial left-to-right shunt and the volume of pulmonary blood flow, with larger shunts having increased risk. In addition, however, the type of defect is important. Only about 10 percent of patients with unrepaired atrial septal defects develop the Eisenmenger syndrome, compared to 50 percent of patients with unrepaired ventricular septal defects and nearly all patients with unrepaired truncus arteriosus [<a href=\"https://www.uptodate.com/contents/evaluation-and-prognosis-of-eisenmenger-syndrome/abstract/5\" class=\"abstract_t\">5</a>].</p><p>The Eisenmenger syndrome has been documented in some patients who never manifested a large left-to-right shunt [<a href=\"https://www.uptodate.com/contents/evaluation-and-prognosis-of-eisenmenger-syndrome/abstract/6,7\" class=\"abstract_t\">6,7</a>]. In fact, it is unusual for the evolution of the syndrome to be documented clinically (especially given the currently available approaches to managing known left-to-right shunts). The temporal pathophysiologic sequence outlined above (<a href=\"image.htm?imageKey=CARD%2F58708\" class=\"graphic graphic_algorithm graphicRef58708 \">algorithm 1</a>) has therefore been called into question; in most patients diagnosed with Eisenmenger syndrome, PAH, right-to-left shunting and cyanosis are found at initial presentation.</p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h2\">Physical examination</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Physical examination of the patient with Eisenmenger syndrome demonstrates central cyanosis and digital clubbing (<a href=\"image.htm?imageKey=PULM%2F52839\" class=\"graphic graphic_figure graphicRef52839 \">figure 2</a> and <a href=\"image.htm?imageKey=CARD%2F77116\" class=\"graphic graphic_picture graphicRef77116 \">picture 2</a>). Most affected patients have diffuse central cyanosis, and clubbing involves all extremities equally. However, in some cases the pattern and degree of cyanosis and clubbing may depend upon the patient's hemodynamic status and the cardiac anatomy. An often discussed example is the patient with a patent ductus arteriosus and Eisenmenger syndrome, in whom the right-to-left shunt through the ductus typically delivers unoxygenated blood distal to the left subclavian artery. This can result in differential cyanosis and clubbing that may be more pronounced in the lower extremities.</p><p>The cardiovascular examination reveals findings consistent with the presence of PAH. (See <a href=\"topic.htm?path=classification-and-prognosis-of-pulmonary-hypertension-in-adults\" class=\"medical medical_review\">&quot;Classification and prognosis of pulmonary hypertension in adults&quot;</a>.)</p><p>Early physical signs include:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The jugular venous pulse is usually normal when the shunt is distal to the tricuspid valve. In other cases, a prominent &quot;a&quot; wave is seen, due to right atrial contraction that generates a high pressure in order to fill the dilated and hypertrophied right ventricle (<a href=\"image.htm?imageKey=CARD%2F81625\" class=\"graphic graphic_figure graphicRef81625 \">figure 3</a>). (See <a href=\"topic.htm?path=examination-of-the-jugular-venous-pulse\" class=\"medical medical_review\">&quot;Examination of the jugular venous pulse&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>A right ventricular impulse and a palpable pulmonary closure sound (P2) are commonly found on precordial palpation.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>There is usually no murmur, but an ejection sound is common due to dilatation of the pulmonary artery. (See <a href=\"topic.htm?path=auscultation-of-cardiac-murmurs-in-adults\" class=\"medical medical_review\">&quot;Auscultation of cardiac murmurs in adults&quot;</a> and <a href=\"topic.htm?path=auscultation-of-heart-sounds\" class=\"medical medical_review\">&quot;Auscultation of heart sounds&quot;</a>.)</p><p/><p>With progressive right heart failure, the following changes become apparent:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The mean jugular venous pressure increases, as does the magnitude of the &quot;a&quot; wave. With the development of tricuspid regurgitation, the &quot;v&quot; wave also increases. (See <a href=\"topic.htm?path=examination-of-the-jugular-venous-pulse\" class=\"medical medical_review\">&quot;Examination of the jugular venous pulse&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The increase in venous pressure <span class=\"nowrap\">and/or</span> neurohormonal activation can lead to peripheral edema, hepatomegaly, and ascites [<a href=\"https://www.uptodate.com/contents/evaluation-and-prognosis-of-eisenmenger-syndrome/abstract/8,9\" class=\"abstract_t\">8,9</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Murmurs of tricuspid and pulmonic regurgitation become audible and occasionally palpable. Tricuspid regurgitation in this setting is secondary to dilatation of the tricuspid annulus and right ventricle, and is not a sign of valve disease [<a href=\"https://www.uptodate.com/contents/evaluation-and-prognosis-of-eisenmenger-syndrome/abstract/10\" class=\"abstract_t\">10</a>]. (See <a href=\"topic.htm?path=auscultation-of-cardiac-murmurs-in-adults\" class=\"medical medical_review\">&quot;Auscultation of cardiac murmurs in adults&quot;</a> and <a href=\"topic.htm?path=etiology-clinical-features-and-evaluation-of-tricuspid-regurgitation\" class=\"medical medical_review\">&quot;Etiology, clinical features, and evaluation of tricuspid regurgitation&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H6\"><span class=\"h1\">PROGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The mean age at death of patients with Eisenmenger physiology has been reported to be 37 years or less, although the individual clinical course is quite variable. Most patients are thought to die from progressive cardiovascular disease and heart failure, from sudden cardiac death, or from intrapulmonary hemorrhage due to rupture of a major vessel [<a href=\"https://www.uptodate.com/contents/evaluation-and-prognosis-of-eisenmenger-syndrome/abstract/4,11,12\" class=\"abstract_t\">4,11,12</a>]. Although some patients with Eisenmenger syndrome survive into their 60s and beyond [<a href=\"https://www.uptodate.com/contents/evaluation-and-prognosis-of-eisenmenger-syndrome/abstract/11-15\" class=\"abstract_t\">11-15</a>], survival is generally limited.</p><p>A systematic review included 12 studies of 1131 patients not treated with advanced therapy for pulmonary hypertension and adjusted for immortal time bias found in many reports; the adjusted 10-year mortality rates ranged between 30 and 40 percent [<a href=\"https://www.uptodate.com/contents/evaluation-and-prognosis-of-eisenmenger-syndrome/abstract/16\" class=\"abstract_t\">16</a>]. Although mortality rates in the 1950s and 1960s were worse, similar mortality rates were observed in patients studied from the 1970s to the 2000s.</p><p>In a later multicenter study of 1098 patients (median age 34.4 years, range 16.1 to 84.4 years), with median follow-up of 3.1 years, significant predictors of death on multivariable analysis included age (HR 1.<span class=\"nowrap\">41/10</span> years, 95% CI 1.24 to 1.59), pre-tricuspid shunt (HR 1.56, 95% CI 1.02 to 2.39), and presence of pericardial effusion (HR 2.41, 95% CI 1.59 to 3.66); lower risk was seen with higher oxygen saturation at rest (HR 0.<span class=\"nowrap\">53/10</span> percent, 95% CI 0.42 to 0.64) and with sinus rhythm (HR 0.53, 95% CI 0.32 to 0.88) [<a href=\"https://www.uptodate.com/contents/evaluation-and-prognosis-of-eisenmenger-syndrome/abstract/15\" class=\"abstract_t\">15</a>].</p><p>Smaller earlier studies found that patients with complex congenital heart disease had earlier clinical deterioration (eg, mean age 19 versus 27 years [<a href=\"https://www.uptodate.com/contents/evaluation-and-prognosis-of-eisenmenger-syndrome/abstract/12\" class=\"abstract_t\">12</a>]) and shorter survival (mean age 26 versus 33 years [<a href=\"https://www.uptodate.com/contents/evaluation-and-prognosis-of-eisenmenger-syndrome/abstract/12\" class=\"abstract_t\">12</a>]) than those with simple congenital heart disease. In a series of 171 Eisenmenger patients, median survival was reduced by about 20 years in those with simple underlying lesions and by about 40 years in those with complex lesions compared with healthy individuals [<a href=\"https://www.uptodate.com/contents/evaluation-and-prognosis-of-eisenmenger-syndrome/abstract/14\" class=\"abstract_t\">14</a>]. Predictors of mortality included functional class, signs of heart failure, history of clinical arrhythmias, QRS duration and QTc interval, low serum albumin, and low potassium levels. Hemoptysis is common (20 percent in one series) but may not affect prognosis [<a href=\"https://www.uptodate.com/contents/evaluation-and-prognosis-of-eisenmenger-syndrome/abstract/12\" class=\"abstract_t\">12</a>].</p><p>However, Eisenmenger patients have a better life expectancy than patients with primary pulmonary hypertension (PPH) who have similar hemodynamics [<a href=\"https://www.uptodate.com/contents/evaluation-and-prognosis-of-eisenmenger-syndrome/abstract/17,18\" class=\"abstract_t\">17,18</a>]. This was illustrated in a report of patients with severe PAH (37 Eisenmenger, 57 PPH) [<a href=\"https://www.uptodate.com/contents/evaluation-and-prognosis-of-eisenmenger-syndrome/abstract/17\" class=\"abstract_t\">17</a>]. Actuarial survival at one and three years of those not receiving transplants was higher in those with Eisenmenger syndrome (97 versus 77 percent and 77 versus 35 percent, respectively). This difference may be related, in part, to the preservation of biventricular function in Eisenmenger patients, with the potential for biventricular sharing of the hemodynamic loading conditions [<a href=\"https://www.uptodate.com/contents/evaluation-and-prognosis-of-eisenmenger-syndrome/abstract/19\" class=\"abstract_t\">19</a>]. (See <a href=\"topic.htm?path=classification-and-prognosis-of-pulmonary-hypertension-in-adults\" class=\"medical medical_review\">&quot;Classification and prognosis of pulmonary hypertension in adults&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H7\"><span class=\"h1\">EVALUATION FOR CONGENITAL HEART DISEASE RELATED PULMONARY ARTERIAL HYPERTENSION</span></p><p class=\"headingAnchor\" id=\"H8\"><span class=\"h2\">Initial evaluation</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>We agree with the 2008 American College of <span class=\"nowrap\">Cardiology/American</span> Heart Association <span class=\"nowrap\">(ACC/AHA)</span> guidelines recommendations for the following noninvasive assessment in all adult congenital heart disease (CHD) patients with suspected pulmonary artery hypertension (PAH) [<a href=\"https://www.uptodate.com/contents/evaluation-and-prognosis-of-eisenmenger-syndrome/abstract/20\" class=\"abstract_t\">20</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Pulse oximetry, with and without administration of supplemental oxygen, as appropriate. Finger and toe oximetry in those with suspected Eisenmenger syndrome.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Electrocardiogram (ECG). The ECG may demonstrate right or biventricular hypertrophy with associated ST-T wave changes (<a href=\"image.htm?imageKey=CARD%2F67622\" class=\"graphic graphic_waveform graphicRef67622 \">waveform 1</a>). There may also be evidence of a right atrial abnormality (a tall, narrow P wave) (<a href=\"image.htm?imageKey=CARD%2F64928\" class=\"graphic graphic_waveform graphicRef64928 \">waveform 2</a> and <a href=\"image.htm?imageKey=CARD%2F78126\" class=\"graphic graphic_waveform graphicRef78126 \">waveform 3</a>). (See <a href=\"topic.htm?path=ecg-tutorial-chamber-enlargement-and-hypertrophy\" class=\"medical medical_review\">&quot;ECG tutorial: Chamber enlargement and hypertrophy&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Chest radiograph. The chest radiograph usually shows dilatation of the central pulmonary arteries, peripheral pulmonary artery &quot;pruning&quot; (abrupt attenuation <span class=\"nowrap\">and/or</span> termination of peripheral pulmonary artery branches), neovascularity, which is better seen on computed tomography (CT) scan [<a href=\"https://www.uptodate.com/contents/evaluation-and-prognosis-of-eisenmenger-syndrome/abstract/21\" class=\"abstract_t\">21</a>], and right heart enlargement (<a href=\"image.htm?imageKey=CARD%2F74023\" class=\"graphic graphic_diagnosticimage graphicRef74023 \">image 1</a>).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Complete blood count and nuclear lung scintigraphy.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Cardiovascular imaging via transthoracic echocardiography (TTE), transesophageal echocardiography (TEE), cardiovascular magnetic resonance imaging (CMRI), or CT.</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Imaging findings can include signs of chronic right ventricular pressure overload. The elevation in pressure leads to increased right ventricular wall thickness with paradoxical bulging of the septum into the left ventricle during systole (<a href=\"image.htm?imageKey=CARD%2F77640\" class=\"graphic graphic_figure graphicRef77640 \">figure 4</a>). With more advanced disease, right ventricular dilatation and hypokinesis occur, the septum shows abnormal diastolic flattening, and right atrial dilatation and tricuspid and pulmonic regurgitation are seen (<a href=\"image.htm?imageKey=CARD%2F55501\" class=\"graphic graphic_movie graphicRef55501 \">movie 1</a> and <a href=\"image.htm?imageKey=CARD%2F67911\" class=\"graphic graphic_movie graphicRef67911 \">movie 2</a>).</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Imaging also may demonstrate the underlying cardiac defect responsible for the initial left-to-right shunt (<a href=\"image.htm?imageKey=CARD%2F80448\" class=\"graphic graphic_movie graphicRef80448 \">movie 3</a> and <a href=\"image.htm?imageKey=CARD%2F79348\" class=\"graphic graphic_movie graphicRef79348 \">movie 4</a> and <a href=\"image.htm?imageKey=CARD%2F57768\" class=\"graphic graphic_movie graphicRef57768 \">movie 5</a> and <a href=\"image.htm?imageKey=CARD%2F57251\" class=\"graphic graphic_movie graphicRef57251 \">movie 6</a>). Delineation of the cardiac defect may be difficult with transthoracic echocardiography due to equalization of pressures in the right and left heart.</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Two-dimensional echocardiography may be limited by poor acoustic windows in patients with PAH. Transesophageal echocardiography should be considered in patients with suboptimal transthoracic images, presenting with PAH in an effort to exclude congenital heart disease. Transesophageal echocardiography may be contraindicated in some patients given the potential risk of sedation. Agitated saline contrast can be helpful in confirming a suspected intracardiac shunt but should be avoided when a large intracardiac shunt has been established. (See <a href=\"topic.htm?path=management-of-eisenmenger-syndrome#H18\" class=\"medical medical_review\">&quot;Management of Eisenmenger syndrome&quot;, section on 'Noncardiac surgery'</a>.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>CT and CT angiography of the pulmonary arteries can reveal enlargement, thrombosis, and mural calcification of the pulmonary trunk and its proximal branches [<a href=\"https://www.uptodate.com/contents/evaluation-and-prognosis-of-eisenmenger-syndrome/abstract/22,23\" class=\"abstract_t\">22,23</a>]. Within the lung parenchyma, embolic infarction, hemorrhage, neovascularity, lobular ground glass opacification, and hilar and intercostal collaterals may also be seen [<a href=\"https://www.uptodate.com/contents/evaluation-and-prognosis-of-eisenmenger-syndrome/abstract/21\" class=\"abstract_t\">21</a>]. The last three abnormalities appear to occur more frequently in cyanotic than in acyanotic PAH and may correspond to the histologic findings of malformed, dilated muscular arteries within the alveolar septae, and congested capillaries within the walls of both alveoli and medium-sized pulmonary arteries [<a href=\"https://www.uptodate.com/contents/evaluation-and-prognosis-of-eisenmenger-syndrome/abstract/21\" class=\"abstract_t\">21</a>]. These lesions are more common and more severe with post-tricuspid right-to-left shunts at the level of the ventricles or great arteries.</p><p/><p class=\"headingAnchor\" id=\"H9\"><span class=\"h2\">Additional testing</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>If PAH is identified but its cause is not recognized, additional testing should include the following [<a href=\"https://www.uptodate.com/contents/evaluation-and-prognosis-of-eisenmenger-syndrome/abstract/20\" class=\"abstract_t\">20</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Pulmonary function tests with volumes and diffusion capacity (diffusing capacity of the lung for carbon monoxide).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Overnight oximetry to screen for obstructive sleep apnea.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Pulmonary embolism protocol CT with parenchymal lung windows or ventilation perfusion (VQ) scan.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Additional testing as appropriate to rule out contributing causes of PAH.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>A six-minute walk test or similar exercise test may be considered as part of the functional assessment. This also provides information about oxygen saturation with exercise.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Cardiac catheterization at least once, with potential for vasodilator testing or anatomic intervention, at a center with expertise in catheterization, PAH, and management of CHD-PAH. Cardiac catheterization enables characterization of the cardiac shunt and determination of pulmonary vascular resistance (PVR) and responsiveness to vasodilators. (See <a href=\"topic.htm?path=clinical-features-and-diagnosis-of-pulmonary-hypertension-in-adults\" class=\"medical medical_review\">&quot;Clinical features and diagnosis of pulmonary hypertension in adults&quot;</a>.)</p><p/><p>There are a multitude of factors that may confound the hemodynamic evaluation and quantification of PAH in the Eisenmenger syndrome, especially in patients with complex congenital heart disease. These may include:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Pulmonary venous hypertension due to left atrial hypertension or atrioventricular valve regurgitation.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Pulmonary venous obstruction.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Pulmonary parenchymal disease or restrictive lung disease.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In situ pulmonary artery thrombosis.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Altered anatomic relations and hemodynamics that may impede routine catheter advancement and positioning.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>PVR is flow dependent so it may not necessarily fall in proportion to the reduction in shunt and pulmonary blood flow.</p><p/><p class=\"headingAnchor\" id=\"H10\"><span class=\"h2\">Additional evaluation for suspected Eisenmenger syndrome</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Evaluation of suspected Eisenmenger physiology includes a detailed history for all past medical and surgical interventions, thorough understanding of past and current anatomy, and evaluation of degree of PAH, ventricular function, and any secondary complications [<a href=\"https://www.uptodate.com/contents/evaluation-and-prognosis-of-eisenmenger-syndrome/abstract/20\" class=\"abstract_t\">20</a>].</p><p>Evaluation should include all the above initially and additional testing plus ferritin and iron studies, renal and hepatic function tests, and six-minute walk testing.</p><p>Lung biopsy is <strong>NOT</strong> routinely used in diagnosing Eisenmenger syndrome. This was previously performed to determine the degree of pulmonary vascular disease. However, it is now recognized that this information can be obtained by noninvasive methods and the procedural risks exceed the benefits. However, when a biopsy is obtained, characteristic histologic features are seen (<a href=\"image.htm?imageKey=CARD%2F64141\" class=\"graphic graphic_picture graphicRef64141 \">picture 1</a>)&nbsp;[<a href=\"https://www.uptodate.com/contents/evaluation-and-prognosis-of-eisenmenger-syndrome/abstract/24,25\" class=\"abstract_t\">24,25</a>]. The histologic grading of pulmonary vascular disease in patients with congenital heart disease is discussed separately. (See <a href=\"topic.htm?path=the-epidemiology-and-pathogenesis-of-pulmonary-arterial-hypertension-group-1#H7\" class=\"medical medical_review\">&quot;The epidemiology and pathogenesis of pulmonary arterial hypertension (Group 1)&quot;, section on 'Congenital heart disease'</a>.)</p><p class=\"headingAnchor\" id=\"H76487592\"><span class=\"h1\">SOCIETY GUIDELINE LINKS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See <a href=\"topic.htm?path=society-guideline-links-pulmonary-hypertension-in-adults\" class=\"medical medical_society_guidelines\">&quot;Society guideline links: Pulmonary hypertension in adults&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H11\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Eisenmenger syndrome is the triad of congenital systemic-to-pulmonary cardiovascular communication, pulmonary arterial disease causing severe pulmonary hypertension, and cyanosis. The development of pulmonary arterial disease is a consequence of increased pulmonary blood flow, and requires exclusion of other causes of pulmonary hypertension.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Physical examination of the patient with Eisenmenger syndrome generally demonstrates central cyanosis and digital clubbing. Common findings include a right ventricular impulse and a palpable pulmonary closure sound (P2).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Life expectancy is generally more severely reduced in Eisenmenger patients with complex congenital heart disease than in Eisenmenger patients with simple lesions such as ventricular septal defect, atrial septal defect, and patent ductus arteriosus.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Eisenmenger patients have a better life expectancy than patients with pulmonary arterial hypertension who have similar hemodynamics.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Evaluation for congenital heart disease related pulmonary arterial hypertension should include noninvasive assessment of cardiopulmonary anatomy and function. If evaluation by cardiac catheterization is indicated, the procedure should be performed in a center with expertise in managing congenital heart disease related pulmonary arterial hypertension.</p><p/><p class=\"headingAnchor\" id=\"H347896251\"><span class=\"h1\">ACKNOWLEDGMENT</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The UpToDate editorial staff would like to thank Dr. Thomas P. Graham, Jr. for his contributions as a Section Editor to previous versions of this topic review.</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/evaluation-and-prognosis-of-eisenmenger-syndrome/abstract/1\" class=\"nounderline abstract_t\">Eisenmenger, V. Die Angeboren Defect der Kammer scheiderwand des Herzens. Z Klin Med Suppl 1897; 32:1.</a></li><li><a href=\"https://www.uptodate.com/contents/evaluation-and-prognosis-of-eisenmenger-syndrome/abstract/2\" class=\"nounderline abstract_t\">WOOD P. The Eisenmenger syndrome or pulmonary hypertension with reversed central shunt. I. Br Med J 1958; 2:701.</a></li><li><a href=\"https://www.uptodate.com/contents/evaluation-and-prognosis-of-eisenmenger-syndrome/abstract/3\" class=\"nounderline abstract_t\">Vongpatanasin W, Brickner ME, Hillis LD, Lange RA. The Eisenmenger syndrome in adults. Ann Intern Med 1998; 128:745.</a></li><li><a href=\"https://www.uptodate.com/contents/evaluation-and-prognosis-of-eisenmenger-syndrome/abstract/4\" class=\"nounderline abstract_t\">Saha A, Balakrishnan KG, Jaiswal PK, et al. Prognosis for patients with Eisenmenger syndrome of various aetiology. Int J Cardiol 1994; 45:199.</a></li><li><a href=\"https://www.uptodate.com/contents/evaluation-and-prognosis-of-eisenmenger-syndrome/abstract/5\" class=\"nounderline abstract_t\">Granton JT, Rabinovitch M. Pulmonary arterial hypertension in congenital heart disease. Cardiol Clin 2002; 20:441.</a></li><li><a href=\"https://www.uptodate.com/contents/evaluation-and-prognosis-of-eisenmenger-syndrome/abstract/6\" class=\"nounderline abstract_t\">Blieden LC, Moller JH. Small ventricular septal defect associated with severe pulmonary hypertension. Br Heart J 1984; 52:117.</a></li><li><a href=\"https://www.uptodate.com/contents/evaluation-and-prognosis-of-eisenmenger-syndrome/abstract/7\" class=\"nounderline abstract_t\">Bisset GS 3rd, Hirschfeld SS. Severe pulmonary hypertension associated with a small ventricular septal defect. Circulation 1983; 67:470.</a></li><li><a href=\"https://www.uptodate.com/contents/evaluation-and-prognosis-of-eisenmenger-syndrome/abstract/8\" class=\"nounderline abstract_t\">Bolger AP, Sharma R, Li W, et al. Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease. Circulation 2002; 106:92.</a></li><li><a href=\"https://www.uptodate.com/contents/evaluation-and-prognosis-of-eisenmenger-syndrome/abstract/9\" class=\"nounderline abstract_t\">Ohuchi H, Takasugi H, Ohashi H, et al. Stratification of pediatric heart failure on the basis of neurohormonal and cardiac autonomic nervous activities in patients with congenital heart disease. Circulation 2003; 108:2368.</a></li><li><a href=\"https://www.uptodate.com/contents/evaluation-and-prognosis-of-eisenmenger-syndrome/abstract/10\" class=\"nounderline abstract_t\">Mikami T, Kudo T, Sakurai N, et al. Mechanisms for development of functional tricuspid regurgitation determined by pulsed Doppler and two-dimensional echocardiography. Am J Cardiol 1984; 53:160.</a></li><li><a href=\"https://www.uptodate.com/contents/evaluation-and-prognosis-of-eisenmenger-syndrome/abstract/11\" class=\"nounderline abstract_t\">Niwa K, Perloff JK, Kaplan S, et al. Eisenmenger syndrome in adults: ventricular septal defect, truncus arteriosus, univentricular heart. J Am Coll Cardiol 1999; 34:223.</a></li><li><a href=\"https://www.uptodate.com/contents/evaluation-and-prognosis-of-eisenmenger-syndrome/abstract/12\" class=\"nounderline abstract_t\">Daliento L, Somerville J, Presbitero P, et al. Eisenmenger syndrome. Factors relating to deterioration and death. Eur Heart J 1998; 19:1845.</a></li><li><a href=\"https://www.uptodate.com/contents/evaluation-and-prognosis-of-eisenmenger-syndrome/abstract/13\" class=\"nounderline abstract_t\">Warnes CA, Boger JE, Roberts WC. Eisenmenger ventricular septal defect with prolonged survival. Am J Cardiol 1984; 54:460.</a></li><li><a href=\"https://www.uptodate.com/contents/evaluation-and-prognosis-of-eisenmenger-syndrome/abstract/14\" class=\"nounderline abstract_t\">Diller GP, Dimopoulos K, Broberg CS, et al. Presentation, survival prospects, and predictors of death in Eisenmenger syndrome: a combined retrospective and case-control study. Eur Heart J 2006; 27:1737.</a></li><li><a href=\"https://www.uptodate.com/contents/evaluation-and-prognosis-of-eisenmenger-syndrome/abstract/15\" class=\"nounderline abstract_t\">Kempny A, Hjortsh&oslash;j CS, Gu H, et al. Predictors of Death in Contemporary Adult Patients With Eisenmenger Syndrome: A Multicenter Study. Circulation 2017; 135:1432.</a></li><li><a href=\"https://www.uptodate.com/contents/evaluation-and-prognosis-of-eisenmenger-syndrome/abstract/16\" class=\"nounderline abstract_t\">Diller GP, Kempny A, Inuzuka R, et al. Survival prospects of treatment na&iuml;ve patients with Eisenmenger: a systematic review of the literature and report of own experience. Heart 2014; 100:1366.</a></li><li><a href=\"https://www.uptodate.com/contents/evaluation-and-prognosis-of-eisenmenger-syndrome/abstract/17\" class=\"nounderline abstract_t\">Hopkins WE, Ochoa LL, Richardson GW, Trulock EP. Comparison of the hemodynamics and survival of adults with severe primary pulmonary hypertension or Eisenmenger syndrome. J Heart Lung Transplant 1996; 15:100.</a></li><li><a href=\"https://www.uptodate.com/contents/evaluation-and-prognosis-of-eisenmenger-syndrome/abstract/18\" class=\"nounderline abstract_t\">Hayden AM, Robert RC, Kriett JM, et al. Primary diagnosis predicts prognosis of lung transplant candidates. Transplantation 1993; 55:1048.</a></li><li><a href=\"https://www.uptodate.com/contents/evaluation-and-prognosis-of-eisenmenger-syndrome/abstract/19\" class=\"nounderline abstract_t\">Hopkins WE, Waggoner AD. Severe pulmonary hypertension without right ventricular failure: the unique hearts of patients with Eisenmenger syndrome. Am J Cardiol 2002; 89:34.</a></li><li><a href=\"https://www.uptodate.com/contents/evaluation-and-prognosis-of-eisenmenger-syndrome/abstract/20\" class=\"nounderline abstract_t\">Warnes CA, Williams RG, Bashore TM, et al. ACC/AHA 2008 Guidelines for the Management of Adults with Congenital Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines on the management of adults with congenital heart disease). Circulation 2008; 118:e714.</a></li><li><a href=\"https://www.uptodate.com/contents/evaluation-and-prognosis-of-eisenmenger-syndrome/abstract/21\" class=\"nounderline abstract_t\">Sheehan R, Perloff JK, Fishbein MC, et al. Pulmonary neovascularity: a distinctive radiographic finding in Eisenmenger syndrome. Circulation 2005; 112:2778.</a></li><li><a href=\"https://www.uptodate.com/contents/evaluation-and-prognosis-of-eisenmenger-syndrome/abstract/22\" class=\"nounderline abstract_t\">Perloff JK, Hart EM, Greaves SM, et al. Proximal pulmonary arterial and intrapulmonary radiologic features of Eisenmenger syndrome and primary pulmonary hypertension. Am J Cardiol 2003; 92:182.</a></li><li><a href=\"https://www.uptodate.com/contents/evaluation-and-prognosis-of-eisenmenger-syndrome/abstract/23\" class=\"nounderline abstract_t\">Silversides CK, Granton JT, Konen E, et al. Pulmonary thrombosis in adults with Eisenmenger syndrome. J Am Coll Cardiol 2003; 42:1982.</a></li><li><a href=\"https://www.uptodate.com/contents/evaluation-and-prognosis-of-eisenmenger-syndrome/abstract/24\" class=\"nounderline abstract_t\">HEATH D, EDWARDS JE. The pathology of hypertensive pulmonary vascular disease; a description of six grades of structural changes in the pulmonary arteries with special reference to congenital cardiac septal defects. Circulation 1958; 18:533.</a></li><li><a href=\"https://www.uptodate.com/contents/evaluation-and-prognosis-of-eisenmenger-syndrome/abstract/25\" class=\"nounderline abstract_t\">Rabinovitch M, Haworth SG, Castaneda AR, et al. Lung biopsy in congenital heart disease: a morphometric approach to pulmonary vascular disease. Circulation 1978; 58:1107.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 1414 Version 11.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H11\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">GENERAL FEATURES</a><ul><li><a href=\"#H3\" id=\"outline-link-H3\">Anatomy and physiology</a><ul><li><a href=\"#H4\" id=\"outline-link-H4\">- Shunt size and defect type</a></li></ul></li><li><a href=\"#H5\" id=\"outline-link-H5\">Physical examination</a></li></ul></li><li><a href=\"#H6\" id=\"outline-link-H6\">PROGNOSIS</a></li><li><a href=\"#H7\" id=\"outline-link-H7\">EVALUATION FOR CONGENITAL HEART DISEASE RELATED PULMONARY ARTERIAL HYPERTENSION</a><ul><li><a href=\"#H8\" id=\"outline-link-H8\">Initial evaluation</a></li><li><a href=\"#H9\" id=\"outline-link-H9\">Additional testing</a></li><li><a href=\"#H10\" id=\"outline-link-H10\">Additional evaluation for suspected Eisenmenger syndrome</a></li></ul></li><li><a href=\"#H76487592\" id=\"outline-link-H76487592\">SOCIETY GUIDELINE LINKS</a></li><li><a href=\"#H11\" id=\"outline-link-H11\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#H347896251\" id=\"outline-link-H347896251\">ACKNOWLEDGMENT</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"CARD/1414|ALG\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"ALGORITHMS\">ALGORITHMS</a></div><ul><li><a href=\"image.htm?imageKey=CARD/58708\" class=\"graphic graphic_algorithm\">- Pathophysiology Eisenmenger</a></li></ul></li><li><div id=\"CARD/1414|DiagnosticImage\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"DIAGNOSTIC IMAGES\">DIAGNOSTIC IMAGES</a></div><ul><li><a href=\"image.htm?imageKey=CARD/74023\" class=\"graphic graphic_diagnosticimage\">- CXR of Eisenmenger syndrome </a></li></ul></li><li><div id=\"CARD/1414|FIG\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"FIGURES\">FIGURES</a></div><ul><li><a href=\"image.htm?imageKey=CARD/52487\" class=\"graphic graphic_figure\">- Pathophysiology VSD</a></li><li><a href=\"image.htm?imageKey=CARD/70502\" class=\"graphic graphic_figure\">- Eisenmenger syndrome anatomy and physiology</a></li><li><a href=\"image.htm?imageKey=PULM/52839\" class=\"graphic graphic_figure\">- Clubbing of the fingers</a></li><li><a href=\"image.htm?imageKey=CARD/81625\" class=\"graphic graphic_figure\">- Eisenmenger heart specimen</a></li><li><a href=\"image.htm?imageKey=CARD/77640\" class=\"graphic graphic_figure\">- Schematic of echo findings in PH</a></li></ul></li><li><div id=\"CARD/1414|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=CARD/64141\" class=\"graphic graphic_picture\">- Intimal hyperplasia in PAH</a></li><li><a href=\"image.htm?imageKey=CARD/77116\" class=\"graphic graphic_picture\">- Finger clubbing cyanosis</a></li></ul></li><li><div id=\"CARD/1414|MOV\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"MOVIES\">MOVIES</a></div><ul><li><a href=\"image.htm?imageKey=CARD/55501\" class=\"graphic graphic_movie\">- Pulmonary hypertension four chamber echocardiogram</a></li><li><a href=\"image.htm?imageKey=CARD/67911\" class=\"graphic graphic_movie\">- Pulmonary hypertension short axis echo</a></li><li><a href=\"image.htm?imageKey=CARD/80448\" class=\"graphic graphic_movie\">- TTE two ASDs</a></li><li><a href=\"image.htm?imageKey=CARD/79348\" class=\"graphic graphic_movie\">- TEE ASD</a></li><li><a href=\"image.htm?imageKey=CARD/57768\" class=\"graphic graphic_movie\">- VSD short axis color Doppler echo</a></li><li><a href=\"image.htm?imageKey=CARD/57251\" class=\"graphic graphic_movie\">- VSD small four chamber color Doppler echo</a></li></ul></li><li><div id=\"CARD/1414|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=CARD/55944\" class=\"graphic graphic_table\">- Causes of Eisenmenger syndrome</a></li></ul></li><li><div id=\"CARD/1414|Waveform\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"WAVEFORMS\">WAVEFORMS</a></div><ul><li><a href=\"image.htm?imageKey=CARD/67622\" class=\"graphic graphic_waveform\">- ECG of right ventricular hypertrophy</a></li><li><a href=\"image.htm?imageKey=CARD/64928\" class=\"graphic graphic_waveform\">- ECG of atrial enlargement</a></li><li><a href=\"image.htm?imageKey=CARD/78126\" class=\"graphic graphic_waveform\">- RA enlargement ECG tutorial</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=auscultation-of-cardiac-murmurs-in-adults\" class=\"medical medical_review\">Auscultation of cardiac murmurs in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=auscultation-of-heart-sounds\" class=\"medical medical_review\">Auscultation of heart sounds</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=classification-and-prognosis-of-pulmonary-hypertension-in-adults\" class=\"medical medical_review\">Classification and prognosis of pulmonary hypertension in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-features-and-diagnosis-of-pulmonary-hypertension-in-adults\" class=\"medical medical_review\">Clinical features and diagnosis of pulmonary hypertension in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=ecg-tutorial-chamber-enlargement-and-hypertrophy\" class=\"medical medical_review\">ECG tutorial: Chamber enlargement and hypertrophy</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=etiology-clinical-features-and-evaluation-of-tricuspid-regurgitation\" class=\"medical medical_review\">Etiology, clinical features, and evaluation of tricuspid regurgitation</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=examination-of-the-jugular-venous-pulse\" class=\"medical medical_review\">Examination of the jugular venous pulse</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=management-of-eisenmenger-syndrome\" class=\"medical medical_review\">Management of Eisenmenger syndrome</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pathophysiology-of-left-to-right-shunts\" class=\"medical medical_review\">Pathophysiology of left-to-right shunts</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=society-guideline-links-pulmonary-hypertension-in-adults\" class=\"medical medical_society_guidelines\">Society guideline links: Pulmonary hypertension in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=the-epidemiology-and-pathogenesis-of-pulmonary-arterial-hypertension-group-1\" class=\"medical medical_review\">The epidemiology and pathogenesis of pulmonary arterial hypertension (Group 1)</a></li></ul></div></div>","javascript":null}